{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:33:53Z","timestamp":1773282833355,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T00:00:00Z","timestamp":1484092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostate International"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.prnil.2017.02.001","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T22:15:59Z","timestamp":1487628959000},"page":"113-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy and safety of silodosin in the treatment of lower urinary tract symptoms in elderly men taking antihypertensive medications"],"prefix":"10.1016","volume":"5","author":[{"given":"Woo Suk","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Chul","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Hoon","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Kyu","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Wook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Yong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prnil.2017.02.001_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40885-014-0012-3","article-title":"2013 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology and diagnosis of hypertension","volume":"21","author":"Shin","year":"2015","journal-title":"Clin Hypertens"},{"key":"10.1016\/j.prnil.2017.02.001_bib2","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.prnil.2017.02.001_bib3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1464-410X.2009.08427.x","article-title":"The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study","volume":"104","author":"Coyne","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.prnil.2017.02.001_bib4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1464-410x.2000.00570.x","article-title":"Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen study of male urogenital tract problems and general health status","volume":"85","author":"Blanker","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.prnil.2017.02.001_bib5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJMcp1106637","article-title":"Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms","volume":"367","author":"Sarma","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.prnil.2017.02.001_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0160-5402(82)90055-9","article-title":"A\u00a0rat model for predicting orthostatic hypotension during acute and chronic antihypertensive drug therapy","volume":"7","author":"Humphrey","year":"1982","journal-title":"J\u00a0Pharmacol Methods"},{"key":"10.1016\/j.prnil.2017.02.001_bib7","first-page":"578","article-title":"Tissue selectivity of KMD-3213 an \u03b11-adrenoceptor antagonist, in human prostate and vasculature","volume":"164","author":"Murata","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.prnil.2017.02.001_bib8","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1248\/bpb.30.1237","article-title":"Prediction of \u03b11-adrenoceptor occupancy in the human prostate from plasma concentrations of silodosin, tamsulosin and terazosin to treat urinary obstruction in benign prostatic hyperplasia","volume":"30","author":"Yamada","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.prnil.2017.02.001_bib9","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","article-title":"Development of a comorbidity index using physician claims data","volume":"53","author":"Klabunde","year":"2000","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.prnil.2017.02.001_bib10","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0026-895X(25)10243-5","article-title":"KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues","volume":"48","author":"Shibata","year":"1995","journal-title":"Mol Pharmacol"},{"issue":"Suppl 2","key":"10.1016\/j.prnil.2017.02.001_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000052229","article-title":"Functional uroselectivity","volume":"33","author":"Martin","year":"1998","journal-title":"Eur Urol"},{"key":"10.1016\/j.prnil.2017.02.001_bib12","first-page":"S1","article-title":"Efficacy of alpha-adrenergic receptor blockers in the treatment of male lower urinary tract symptoms","volume":"11","author":"Roehrborn","year":"2009","journal-title":"Rev Urol"},{"key":"10.1016\/j.prnil.2017.02.001_bib13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.eururo.2010.10.046","article-title":"Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe","volume":"59","author":"Chapple","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.prnil.2017.02.001_bib14","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0149-2918(97)80097-5","article-title":"Coadministration of tamsulosin and three antihypertensive agents in patients with BPH: pharmacodynamics effect","volume":"19","author":"Lowe","year":"1997","journal-title":"Clin Ther"},{"key":"10.1016\/j.prnil.2017.02.001_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/pcan.2010.19","article-title":"Effects of \u03b1-blocker 'add on' treatment on blood pressure in symptomatic BPH with or without concomitant hypertension","volume":"13","author":"Lee","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.prnil.2017.02.001_bib16","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.amjmed.2007.05.009","article-title":"Orthostatic hypotension related hospitalizations in the United States","volume":"120","author":"Shibao","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.prnil.2017.02.001_bib17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/CIRCULATIONAHA.105.598722","article-title":"Orthostatic hypotension predicts mortality in middle-aged adults: the Atherosclerosis Risk In Communities (ARIC) Study","volume":"114","author":"Rose","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.prnil.2017.02.001_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/eurheartj\/ehp329","article-title":"Orthostatic hypotension predicts all-cause mortality and coronary events in middleaged individuals (The Malmo Preventive Project)","volume":"31","author":"Fedorowski","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.prnil.2017.02.001_bib19","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1161\/01.STR.31.10.2307","article-title":"Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987\u20131996","volume":"31","author":"Eigenbrodt","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.prnil.2017.02.001_bib20","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/01.HYP.19.6.508","article-title":"Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group","volume":"19","author":"Rutan","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.prnil.2017.02.001_bib21","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1161\/01.CIR.98.21.2290","article-title":"Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program","volume":"98","author":"Masaki","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.prnil.2017.02.001_bib22","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jama.1997.03540400049030","article-title":"Patterns of orthostatic blood pressure change and their clinical correlates in a frail, elderly population","volume":"277","author":"Ooi","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.prnil.2017.02.001_bib23","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/archinte.162.20.2369","article-title":"Orthostatic hypotension in acute geriatric ward: is it a consistent finding?","volume":"162","author":"Weiss","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.prnil.2017.02.001_bib24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s11906-013-0362-3","article-title":"Current concepts in orthostatic hypotension management","volume":"15","author":"Arnold","year":"2013","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.prnil.2017.02.001_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2710.2005.00629.x","article-title":"High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans","volume":"30","author":"Poon","year":"2005","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.prnil.2017.02.001_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/ageing\/afp192","article-title":"The association between orthostatic hypotension and medication use in the British Women's Heart and Health Study","volume":"39","author":"Kamaruzzaman","year":"2010","journal-title":"Age Ageing"},{"key":"10.1016\/j.prnil.2017.02.001_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1442-2042.2010.02708.x","article-title":"Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia","volume":"18","author":"Yokoyama","year":"2011","journal-title":"Int J Urol"},{"key":"10.1016\/j.prnil.2017.02.001_bib28","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/iju.13088","article-title":"Effectiveness and safety of silodosin in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia: A European phase IV clinical study (SiRE study)","volume":"23","author":"Montorsi","year":"2016","journal-title":"Int J Urol"},{"key":"10.1016\/j.prnil.2017.02.001_bib29","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.urology.2010.03.015","article-title":"Ejaculation disorder is associated with increased efficacy of silodosin for benign prostatic hyperplasia","volume":"76","author":"Homma","year":"2010","journal-title":"Urology"}],"container-title":["Prostate International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S228788821730003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S228788821730003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:59:53Z","timestamp":1762419593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S228788821730003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S228788821730003X"],"URL":"https:\/\/doi.org\/10.1016\/j.prnil.2017.02.001","relation":{},"ISSN":["2287-8882"],"issn-type":[{"value":"2287-8882","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of silodosin in the treatment of lower urinary tract symptoms in elderly men taking antihypertensive medications","name":"articletitle","label":"Article Title"},{"value":"Prostate International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prnil.2017.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Asian Pacific Prostate Society, Published by Elsevier Korea LLC.","name":"copyright","label":"Copyright"}]}}